ADC Therapeutics(ADCT) - 2023 Q4 - Earnings Call Transcript

ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Results Earnings Conference Call March 13, 2024 8:30 AM ET Company Participants Nicole Preiss-Riley - Executive Director, Head of Communications Ameet Mallik - Chief Executive Officer Kristen Herrington-Smith - Chief Commercial Officer Mohamed Zaki - Chief Medical Officer Patrick van Berkel - Chief Scientific Officer Jose Carmona - Chief Financial Officer Conference Call Participants Naureen Quibria - Capital One Securities, Inc. Brian Cheng - J.P. Morgan Gregory Renz ...